Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Warren

Showing results (951-960 of 978) with videos related to

Pageof 98
Sort By:
Diabetes|March 29, 2006
Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretionJames Herrington, Yun-Ping Zhou, Randal M Bugianesi, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, David Gorin, et al.
Drug Safety|June 13, 2019
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy VolunteersJessica Ackert, Khadeeja Mohamed, Jason S Slakter, et al.
Evolutionary Anthropology|June 22, 2019
Hybridization in human evolution: Insights from other organismsRebecca R Ackermann, Michael L Arnold, Marcella D Baiz, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile SulfonamidePengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
Benzazepinone Nav1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, Hyun Ok, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of painSriram Tyagarajan, Prasun K Chakravarty, Min Park, et al.
Journal of Medicinal Chemistry|October 27, 2012
Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic painPengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Scientific Reports|March 22, 2020
Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 InfectionCynthia L Gay, Joann D Kuruc, Shane D Falcinelli, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2022
Incidence and Progression of Fibrotic Lung Disease in an At-Risk CohortMark P Steele, Anna L Peljto, Susan K Mathai, et al.
Pageof 98

Showing results (951-960 of 978) with videos related to

Sort By:
Pageof 98
Diabetes|March 29, 2006
Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretionJames Herrington, Yun-Ping Zhou, Randal M Bugianesi, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, David Gorin, et al.
Drug Safety|June 13, 2019
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy VolunteersJessica Ackert, Khadeeja Mohamed, Jason S Slakter, et al.
Evolutionary Anthropology|June 22, 2019
Hybridization in human evolution: Insights from other organismsRebecca R Ackermann, Michael L Arnold, Marcella D Baiz, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile SulfonamidePengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
Benzazepinone Nav1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, Hyun Ok, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of painSriram Tyagarajan, Prasun K Chakravarty, Min Park, et al.
Journal of Medicinal Chemistry|October 27, 2012
Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic painPengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Scientific Reports|March 22, 2020
Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 InfectionCynthia L Gay, Joann D Kuruc, Shane D Falcinelli, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2022
Incidence and Progression of Fibrotic Lung Disease in an At-Risk CohortMark P Steele, Anna L Peljto, Susan K Mathai, et al.
Pageof 98